Morgan Stanley’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$19.4K Buy
2025
Q1
$8.29K Sell
2024
Q4
$44.7K Sell
2024
Q3
$168K Sell
2024
Q2
$225K Buy
2024
Q1
$401K Buy
2023
Q3
Sell
2023
Q2
$2.1K Buy
2023
Q1
Hold
2022
Q4
Hold
2022
Q2
Sell
2022
Q1
$33K Sell
2021
Q4
$41K Sell
2021
Q3
$275K Sell
2021
Q2
$685K Sell
2021
Q1
$1.24M Buy
2020
Q4
$162K Buy
2020
Q3
$8K Sell
2020
Q2
$18K Buy